DK3598975T3 - Hidtil ukendte kombinationer af en H3-antagonist og en noradrenalin-genoptagelseshæmmer, og de terapeutiske anvendelser deraf - Google Patents
Hidtil ukendte kombinationer af en H3-antagonist og en noradrenalin-genoptagelseshæmmer, og de terapeutiske anvendelser deraf Download PDFInfo
- Publication number
- DK3598975T3 DK3598975T3 DK18306017.7T DK18306017T DK3598975T3 DK 3598975 T3 DK3598975 T3 DK 3598975T3 DK 18306017 T DK18306017 T DK 18306017T DK 3598975 T3 DK3598975 T3 DK 3598975T3
- Authority
- DK
- Denmark
- Prior art keywords
- antagonist
- therapeutic uses
- reuptake inhibitor
- novel combinations
- noradrenaline reuptake
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4453—Non condensed piperidines, e.g. piperocaine only substituted in position 1, e.g. propipocaine, diperodon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
- C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
- C07D295/092—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings with aromatic radicals attached to the chain
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Psychiatry (AREA)
- Addiction (AREA)
- Pain & Pain Management (AREA)
- Emergency Medicine (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Pulmonology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP18306017.7A EP3598975B1 (en) | 2018-07-27 | 2018-07-27 | Novel combinations of a h3 antagonist and a noradrenaline reuptake inhibitor, and the therapeutical uses thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK3598975T3 true DK3598975T3 (da) | 2020-11-02 |
Family
ID=63144936
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK18306017.7T DK3598975T3 (da) | 2018-07-27 | 2018-07-27 | Hidtil ukendte kombinationer af en H3-antagonist og en noradrenalin-genoptagelseshæmmer, og de terapeutiske anvendelser deraf |
Country Status (19)
| Country | Link |
|---|---|
| US (2) | US11229632B2 (da) |
| EP (1) | EP3598975B1 (da) |
| JP (1) | JP2020015724A (da) |
| KR (1) | KR20200012781A (da) |
| CN (1) | CN110772515A (da) |
| AU (1) | AU2019208166A1 (da) |
| BR (1) | BR102019015415A2 (da) |
| CA (1) | CA3050590A1 (da) |
| DK (1) | DK3598975T3 (da) |
| ES (1) | ES2840253T3 (da) |
| HU (1) | HUE052652T2 (da) |
| IL (1) | IL268208B (da) |
| MA (1) | MA46500B1 (da) |
| MX (1) | MX2019008637A (da) |
| PL (1) | PL3598975T3 (da) |
| PT (1) | PT3598975T (da) |
| TN (1) | TN2019000216A1 (da) |
| TW (2) | TW202404587A (da) |
| ZA (1) | ZA201904876B (da) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3378858A1 (en) * | 2017-03-21 | 2018-09-26 | Bioprojet | Tetrahydrate of h3 ligand, its process of preparation and pharmaceutical compositions comprising the same |
| JP7234955B2 (ja) | 2020-01-31 | 2023-03-08 | トヨタ自動車株式会社 | 車両 |
| US20220226331A1 (en) * | 2021-01-20 | 2022-07-21 | Alto Neuroscience, Inc. | Integration of molecular mechanisms in the striatum as a combination drug strategy for the treatment of psychiatric and neurological disorders in which anhedonia or motivation-related dysfunction exists |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1717235A3 (en) | 2005-04-29 | 2007-02-28 | Bioprojet | Phenoxypropylpiperidines and -pyrrolidines and their use as histamine H3-receptor ligands |
| EP3239138A1 (en) * | 2016-04-25 | 2017-11-01 | Sandoz Ag | Hydrogen fumarate salt of 1-[3-[3-(4-chlorophenyl)propoxy]propyl]piperidine |
-
2018
- 2018-07-27 ES ES18306017T patent/ES2840253T3/es active Active
- 2018-07-27 EP EP18306017.7A patent/EP3598975B1/en active Active
- 2018-07-27 PL PL18306017T patent/PL3598975T3/pl unknown
- 2018-07-27 PT PT183060177T patent/PT3598975T/pt unknown
- 2018-07-27 DK DK18306017.7T patent/DK3598975T3/da active
- 2018-07-27 HU HUE18306017A patent/HUE052652T2/hu unknown
-
2019
- 2019-06-04 US US16/431,063 patent/US11229632B2/en active Active
- 2019-07-19 MX MX2019008637A patent/MX2019008637A/es unknown
- 2019-07-22 IL IL268208A patent/IL268208B/en unknown
- 2019-07-22 TN TNP/2019/000216A patent/TN2019000216A1/en unknown
- 2019-07-23 AU AU2019208166A patent/AU2019208166A1/en active Pending
- 2019-07-24 CA CA3050590A patent/CA3050590A1/en active Pending
- 2019-07-25 TW TW112133787A patent/TW202404587A/zh unknown
- 2019-07-25 TW TW108126312A patent/TW202007395A/zh unknown
- 2019-07-25 ZA ZA2019/04876A patent/ZA201904876B/en unknown
- 2019-07-25 KR KR1020190090305A patent/KR20200012781A/ko unknown
- 2019-07-26 MA MA46500A patent/MA46500B1/fr unknown
- 2019-07-26 JP JP2019137983A patent/JP2020015724A/ja active Pending
- 2019-07-26 CN CN201910681199.1A patent/CN110772515A/zh active Pending
- 2019-07-26 BR BR102019015415A patent/BR102019015415A2/pt unknown
-
2021
- 2021-11-26 US US17/456,617 patent/US20220079932A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| EP3598975B1 (en) | 2020-10-21 |
| AU2019208166A1 (en) | 2020-02-13 |
| CN110772515A (zh) | 2020-02-11 |
| EP3598975A1 (en) | 2020-01-29 |
| US20220079932A1 (en) | 2022-03-17 |
| CA3050590A1 (en) | 2020-01-27 |
| ZA201904876B (en) | 2020-05-27 |
| TN2019000216A1 (en) | 2021-01-07 |
| TW202404587A (zh) | 2024-02-01 |
| PT3598975T (pt) | 2020-12-21 |
| IL268208A (en) | 2019-11-28 |
| MA46500A1 (fr) | 2021-01-29 |
| BR102019015415A2 (pt) | 2020-01-28 |
| IL268208B (en) | 2022-09-01 |
| ES2840253T3 (es) | 2021-07-06 |
| RU2019123563A (ru) | 2021-01-26 |
| US11229632B2 (en) | 2022-01-25 |
| JP2020015724A (ja) | 2020-01-30 |
| MX2019008637A (es) | 2020-01-28 |
| MA46500B1 (fr) | 2022-07-29 |
| PL3598975T3 (pl) | 2021-04-19 |
| KR20200012781A (ko) | 2020-02-05 |
| US20200030310A1 (en) | 2020-01-30 |
| HUE052652T2 (hu) | 2021-05-28 |
| TW202007395A (zh) | 2020-02-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA189122S (fr) | Bracelet | |
| DK3746424T3 (da) | Erbb/btk-inhibitorer | |
| MA54901A (fr) | Inhibiteur de 15-pgdh | |
| DK3747512T3 (da) | Forbedret trampolin | |
| DK3598975T3 (da) | Hidtil ukendte kombinationer af en H3-antagonist og en noradrenalin-genoptagelseshæmmer, og de terapeutiske anvendelser deraf | |
| DK3736459T3 (da) | Forankringspunkt | |
| CA189017S (fr) | Basketball | |
| DK3790870T3 (da) | Cyclopentanforbindelser | |
| DK3715661T3 (da) | Forbedret antihviningsmellemlæg | |
| JP1709577S (ja) | ダンベル | |
| JP1709243S (ja) | ダンベル | |
| UA40114S (uk) | Набір ключів комбінованих | |
| TH1902003877S (th) | กำไล | |
| JP1713084S (ja) | 運動補助具 | |
| MA56185A (fr) | Nouveaux intermédiaires spirobicycliques | |
| ES1229512Y (es) | Jamonero | |
| DK3833657T3 (da) | Aminothiolester-forbindelser og anvendelser deraf | |
| DE112020005763A5 (de) | Klavier | |
| CA191289S (fr) | Porte-clés | |
| UA39914S (uk) | Брелок | |
| UA40009S (uk) | Мішень тренувальна | |
| UA40007S (uk) | Мішень тренувальна | |
| CA189695S (fr) | Bracelet | |
| TH190856S (th) | สร้อยข้อมือ | |
| TH190858S (th) | สร้อยข้อมือ |